Source link : https://www.newshealth.biz/health-news/marstacimab-sustains-long-term-bleeding-decrease/
Marstacimab, a novel, investigational monoclonal antibody, shows long-term safety and efficacy in the prevention of bleeding events in patients with hemophilia A as well as B without inhibitors, potentially adding to the toolbox for hemophilia A and representing a first of its kind therapy for hemophilia B. “In the long-term extension study treatment with marstacimab […]
Author : News Health
Publish date : 2024-06-28 05:43:06
Copyright for syndicated content belongs to the linked Source.
Categories